Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Champions Oncology (CSBR) Tax Provisions (2016 - 2026)

Champions Oncology has reported Tax Provisions over the past 16 years, most recently at $42000.0 for Q1 2026.

  • For Q1 2026, Tax Provisions rose 82.61% year-over-year to $42000.0; the TTM value through Jan 2026 reached -$55000.0, down 111.54%, while the annual FY2025 figure was -$75000.0, 134.38% down from the prior year.
  • Tax Provisions for Q1 2026 was $42000.0 at Champions Oncology, up from $18000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $42000.0 in Q1 2026 and troughed at -$129000.0 in Q2 2025.
  • A 5-year average of $2705.9 and a median of $14000.0 in 2022 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: soared 1100.0% in 2023 and later tumbled 505.0% in 2024.
  • Year by year, Tax Provisions stood at $14000.0 in 2022, then fell by 21.43% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then skyrocketed by 63.64% to $18000.0 in 2025, then soared by 133.33% to $42000.0 in 2026.
  • Business Quant data shows Tax Provisions for CSBR at $42000.0 in Q1 2026, $18000.0 in Q4 2025, and $14000.0 in Q3 2025.